PROPAN-2-YL 4-((3S,5AR,6R,7R,8AS)-6-((1E,3S)-4-(2,5-DIFLUOROPHENOXY)-3-HYDROXY-1-BUTEN-1-YL)-7-HYDROXYOCTAHYDRO-2H-CYCLOPENTA(B)OXEPIN-3-YL)BUTANOATE
UNII 9X4952UB72
Substance Identification & Data
This profile provides standardized clinical and technical data for Propan-2-yl 4-((3s,5ar,6r,7r,8as)-6-((1e,3s)-4-(2,5-difluorophenoxy)-3-hydroxy-1-buten-1-yl)-7-hydroxyoctahydro-2h-cyclopenta(b)oxepin-3-yl)butanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9X4952UB72.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1262873-20-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H36F2O6 BKVUSNOUTQMSBE-KXMBGKKBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Propan-2-yl 4-((3s,5ar,6r,7r,8as)-6-((1e,3s)-4-(2,5-difluorophenoxy)-3-hydroxy-1-buten-1-yl)-7-hydroxyoctahydro-2h-cyclopenta(b)oxepin-3-yl)butanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.